Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the Thrombotic RIsk Progression (TRIP) study.

Tantry US, Bliden KP, Suarez TA, Kreutz RP, Dichiara J, Gurbel PA.

Platelets. 2010;21(5):360-7. doi: 10.3109/09537100903548903.

PMID:
20377327
2.

The link between heightened thrombogenicity and inflammation: pre-procedure characterization of the patient at high risk for recurrent events after stenting.

Gurbel PA, Bliden KP, Kreutz RP, Dichiara J, Antonino MJ, Tantry US.

Platelets. 2009 Mar;20(2):97-104. doi: 10.1080/09537100802687666.

PMID:
19235051
3.

C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting.

Kreutz RP, Owens J, Breall JA, Lu D, von der Lohe E, Bolad I, Sinha A, Flockhart DA.

Blood Coagul Fibrinolysis. 2013 Apr;24(3):321-6. doi: 10.1097/MBC.0b013e32835cc193.

4.

Blood cell activation, coagulation, and inflammation in men and women with coronary artery disease.

Lindmark E, Wallentin L, Siegbahn A.

Thromb Res. 2001 Aug 1;103(3):249-59.

PMID:
11672587
5.

C-reactive protein and coronary artery disease.

Auer J, Berent R, Lassnig E, Eber B.

Jpn Heart J. 2002 Nov;43(6):607-19.

6.

Relationship between changes in platelet reactivity and changes in platelet receptor expression induced by physical exercise.

Aurigemma C, Fattorossi A, Sestito A, Sgueglia GA, Farnetti S, Buzzonetti A, Infusino F, Landolfi R, Scambia G, Crea F, Lanza GA.

Thromb Res. 2007;120(6):901-9. Epub 2007 Mar 6.

PMID:
17337041
7.
8.
10.

Levels and values of inflammatory markers in patients with angina pectoris.

Yip HK, Wu CJ, Hang CL, Chang HW, Yang CH, Hsieh YK, Fang CY, Fu M, Yeh KH, Chen MC.

Int Heart J. 2005 Jul;46(4):571-81.

11.

In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy.

Vitale C, Cerquetani E, Wajngarten M, Leonardo F, Silvestri A, Mercuro G, Fini M, Ramires JA, Rosano GM.

Ital Heart J. 2003 Sep;4(9):627-32.

PMID:
14635381
12.

Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.

Kozinski M, Krzewina-Kowalska A, Kubica J, Zbikowska-Gotz M, Dymek G, Piasecki R, Sukiennik A, Grzesk G, Bogdan M, Chojnicki M, Dziedziczko A, Sypniewska G.

Inflamm Res. 2005 May;54(5):187-93.

PMID:
15953990
13.

Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease.

Fang L, Wei H, Mak KH, Xiong Z, Song J, Wang D, Lim YL, Chatterjee S.

Can J Cardiol. 2004 Dec;20(14):1433-8.

PMID:
15614337
14.

Clinical prognostic significance of plasma cystatin C levels among patients with acute coronary syndrome.

Ge C, Ren F, Lu S, Ji F, Chen X, Wu X.

Clin Cardiol. 2009 Nov;32(11):644-8. doi: 10.1002/clc.20672.

16.

C-reactive protein contributes to the hypercoagulable state in coronary artery disease.

Song CJ, Nakagomi A, Chandar S, Cai H, Lim IG, McNeil HP, Freedman SB, Geczy CL.

J Thromb Haemost. 2006 Jan;4(1):98-106.

17.
18.

Relation of vasodilator response of the brachial artery to inflammatory markers in patients with coronary artery disease.

Kang SM, Chung N, Kim JY, Koo BK, Choi D, Jang Y, Cho SY.

Echocardiography. 2002 Nov;19(8):661-7.

PMID:
12487635
19.

Increased platelet reactivity in unstable angina patients is not related to C-reactive protein levels.

Sestito A, Sgueglia GA, Spinelli A, Navarese EP, Infusino F, Crea F, Lanza GA.

Platelets. 2006 Aug;17(5):336-9.

PMID:
16928607
20.

Expression of EMMPRIN (CD147) on circulating platelets in vivo.

Pennings GJ, Yong AS, Kritharides L.

J Thromb Haemost. 2010 Mar;8(3):472-81. doi: 10.1111/j.1538-7836.2009.03716.x. Epub 2009 Dec 7.

Supplemental Content

Support Center